Outcome Sciences Reviews

Even though it was acquired by a significantly larger CRO, the Outcome division still operates as though it's a small, struggling company. Since being acquired, getting anything processed internally has become painfully slow, bringing a once nimble company to a grinding halt. Everyone is under pressure to meet quarterly targets as though we're going to go out of business if we miss a number (and since the company is privately owned, there's no transparency as to what "the number" is that we're supposed to be aiming for). Attempts to discuss professional development or growing into a new position are isolated to your direct manager and often fall on deaf ears, leaving you in a dead-end job even if the position supposedly has a career path. Attrition is incredibly high, and management's response is to focus their attention on trying to retain the newer employees as the ones who have been here for a longer period of time are too jaded to be influenced by their efforts. This divides the workforce into two halves: a younger group with a lot of energy that "expects" to be driven into the ground, and an older group that has families and is too jaded to notice that work goes with them to their kids' soccer games and family vacations.

Company not well established and senior management not sure how to handle tough situations or make business decisions. Company is trying to establish itself in the clinical trial arena without developing a strong foundation. Employee benefits are poor and the company is not flexible about working remotely or vacation.